The implications for europe of revised FDA guidelines for clinical trials with anti-infective agents
- 1 July 1990
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 9 (7) , 552-558
- https://doi.org/10.1007/bf01964302
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Regulation of Investigational DrugsNew England Journal of Medicine, 1989
- Statistical Aspects of Clinical Trials of Antibiotics in Acute InfectionsClinical Infectious Diseases, 1986
- Experimental requirements and scientific principles in case-control studiesJournal of Chronic Diseases, 1985
- Interpretation and Comparison of Treatment Studies for Uncomplicated Urinary Tract Infections in WomenClinical Infectious Diseases, 1985
- Quality of antibiotic clinical trialsJournal of Antimicrobial Chemotherapy, 1984
- Antibiotic Trials in Intra-abdominal InfectionsAnnals of Surgery, 1984
- An Evaluation of the Use of Statistical Methodology in the Journal of Infectious DiseasesThe Journal of Infectious Diseases, 1984
- Clinical Trials and Statistical Verdicts: Probable Grounds for AppealAnnals of Internal Medicine, 1983
- Reporting on Methods in Clinical TrialsNew England Journal of Medicine, 1982
- The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control TrialNew England Journal of Medicine, 1978